Human platelet lysate enables robust expansion of tumor infiltrating lymphocytes from endometrial cancer
Background/objectivesTumor infiltrating lymphocytes (TIL) therapy has yielded promising results in melanoma patients, with an approved product available. TIL therapy is of similar interest to a number of additional malignancies, including endometrial c…